Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline

Raises additional 16M EUR led by Dawn Biopharma, a platform controlled by KKR, with participation from existing investors. Funds will be used to further strengthen growing pipeline of first in class ADC assets, including lead asset targeting uPARAP. Iyona Rajkomar, Managing Partner at…